National Vaccine Injury Compensation Program

National Vaccine Injury Compensation Program. Established by an act of the United States Congress in 1986, this program serves as a no-fault alternative to the traditional tort system for resolving petitions related to vaccine injuries. It was created in response to liability concerns that threatened the stability of the nation's vaccine supply and the participation of pharmaceutical companies in immunization efforts. The program is administered by the Health Resources and Services Administration within the U.S. Department of Health and Human Services, with legal adjudication handled by the United States Court of Federal Claims.

Background and establishment

The program's origins are rooted in the legal and public health crises of the 1970s and 1980s, particularly surrounding the whole-cell pertussis vaccine. A series of high-profile lawsuits, such as those documented in the DTP vaccine controversy, led to skyrocketing liability costs for manufacturers like Wyeth and Lederle Laboratories. This environment prompted some companies to threaten withdrawal from the vaccine market, raising alarms within the Centers for Disease Control and Prevention and the Food and Drug Administration about potential shortages. In response, legislators including Henry Waxman and Orrin Hatch championed the National Childhood Vaccine Injury Act of 1986, which was signed into law by President Ronald Reagan. This landmark legislation aimed to ensure a stable vaccine supply by shielding manufacturers from most civil litigation while providing a streamlined avenue for compensation to affected individuals.

Eligibility and covered vaccines

Eligibility is generally limited to individuals who received a vaccine listed on the Vaccine Injury Table, which is maintained by the Secretary of Health and Human Services and includes immunizations recommended by the Advisory Committee on Immunization Practices. Covered vaccines routinely include those for measles, mumps, and rubella, varicella, influenza, hepatitis B, and human papillomavirus, among others. The table specifies medical conditions and timeframes that are presumed to be caused by vaccination, creating a legal presumption of causation if criteria are met. For injuries not listed on the table, petitioners must prove causation-in-fact. The program primarily covers vaccines administered in the United States, including its territories like Puerto Rico and Guam.

Claims process and adjudication

The claims process begins when an individual, often represented by an attorney, files a petition with the United States Court of Federal Claims, commonly known as the "Vaccine Court." The Department of Justice, through its Civil Division, represents the Secretary of Health and Human Services in the proceedings. Special masters, appointed by judges of the court, oversee the cases, evaluate medical records, and may order hearings. The process involves review by physicians from the Division of Vaccine Injury Compensation and can include testimony from experts at institutions like the Mayo Clinic or Johns Hopkins Hospital. Decisions can be appealed to the United States Court of Appeals for the Federal Circuit and, ultimately, the Supreme Court of the United States.

Compensation and benefits

Awards can cover several categories of loss, including unreimbursable medical expenses, lost earnings, and pain and suffering. In cases of death, a death benefit is provided. The program also provides compensation for legal fees and costs, regardless of the petition's outcome, if filed in good faith. Significant awards have been made for conditions such as Guillain-Barré syndrome following influenza vaccine administration or shoulder injury related to vaccine administration. All compensation is paid from the Vaccine Injury Compensation Trust Fund, which is financed by an excise tax on each dose of covered vaccine sold in the United States.

Program statistics and impact

Since its inception, the program has adjudicated thousands of petitions. Data from the Health Resources and Services Administration show that a majority of claims result in dismissal or a finding of no entitlement to compensation. The trust fund, managed by the Department of the Treasury, has disbursed billions of dollars in awards and legal costs. The program is credited by organizations like the World Health Organization and the American Academy of Pediatrics with helping to maintain high vaccination rates in the United States by ensuring manufacturer participation and public confidence. It operates alongside major immunization initiatives like the Vaccines for Children Program.

Criticisms and controversies

The program has faced sustained criticism from various groups, including some members of the anti-vaccination movement and certain patient advocacy organizations. Critics argue the process is overly adversarial, complex, and slow, citing lengthy delays at the United States Court of Federal Claims. Some, including activists like Robert F. Kennedy Jr., have alleged the Vaccine Injury Table is too restrictive, excluding conditions they believe are linked to immunization. Legal scholars have debated the constitutionality of its liability shield following Supreme Court rulings like Bruesewitz v. Wyeth. Conversely, public health officials from the National Institutes of Health and the Institute of Medicine contend the program balances individual compensation with the societal benefits of widespread vaccination.